Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
365.10    -2.30 (-0.63%)
Bid:
366.50
Ask:
366.80
Spread: 0.30 (0.082%)
Market Cap: £7.50b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Directorate Change

21 May 2018 07:45

RNS Number : 6878O
Marks & Spencer Group PLC
21 May 2018
 

21 May 2018

 

 

 

Marks and Spencer Group PLC

APPOINTMENT OF NON-EXECUTIVE DIRECTORS

 

 

Marks and Spencer Group plc ("M&S") today announces the appointments of Katie Bickerstaffe and Pip McCrostie to its Board as a Non-Executive Directors.

 

Katie has extensive experience of retail transformation from a career in a variety of functions in leading UK retailers and consumer companies. She will bring deep understanding of retail and operations, as well as experience in marketing, people, property, and as a Non-Executive Director, to the M&S brand as it embarks on the first phase of its transformation programme.

 

Pip brings extensive experience of finance and transactions from a career at Ernst & Young where she transformed and led the Global Corporate Finance business. Her understanding of global businesses, M&A, corporate transactions, and as a Non-Executive Director, will bring financial and analytical discipline and skills to our Board.

 

Commenting on the appointments, Archie Norman, Chairman of Marks & Spencer said: "We are delighted to welcome Katie Bickerstaffe and Pip McCrostie to the Board of M&S. As we embark on the first phase of our transformation programme we are building a cohesive and engaged board with deep and relevant skills in retail and business change."

 

Katie and Pip will be put forward for election by shareholders at the Annual General Meeting on 10 July and will be formally appointed to the Board following their election. In addition to being appointed to the Nomination Committee, Katie will join the Remuneration Committee and Pip the Audit Committee on appointment.

 

The company confirms that there is no further information required to be disclosed pursuant to paragraph 9.6.13 of the UK Listing Rules.

 

-Ends-

 

For more information, please call:

M&S Corporate PR 0208 718 1919

 

 

 

NOTES TO EDITORS:

 

Katie Bickerstaffe is currently Chief Executive Designate of the new independent British energy supply and services company that will be created by the proposed merger of SSE plc and innogy SE. Until April 2018, Katie was an Executive Director of Dixons Carphone plc where she was Chief Executive, UK and Ireland. She joined Dixons in 2008 and was appointed to its Board in 2012. Prior to this she worked with many well-known food retail and consumer companies including, Kwik Save, PepsiCo, Unilever, Dyson, and Somerfield. Katie has non-executive experience having served as a Non-Executive Director of SSE and chair of the SSE Remuneration Committee.

 

Pip McCrostie was a member of EY's Global Executive team, the organisation's highest management body, acting as global leader of Corporate Finance, one of EY's four global businesses. During her time with EY, Pip played key roles in major transactions in the U.S. and Europe. Pip was also the founder of the Global Transaction Tax network and co-founded the U.K. Transaction Tax group. Pip has non-executive experience: she has been a Non-Executive Director of Inmarsat since 2016 and is also a member of the Peterson Institute for International Economics Board of Directors and chair of its audit committee. She is a regular contributor on business issues.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADMGZKVMZGRZG
Date   Source Headline
1st Jun 202610:00 amRNSAnnual Financial Report
1st Jun 20269:00 amRNSIssue of Shares and Total Voting Rights
28th May 20264:23 pmRNSLichfield Fulfilment Centre Disposal Completion
28th May 20262:12 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
20th May 202610:30 amRNSDirectorate change
20th May 20267:00 amRNSFinal Results
1st May 20269:00 amRNSIssue of Shares and Total Voting Rights
28th Apr 20262:57 pmRNSDirector/PDMR Shareholding
28th Apr 202610:40 amRNSHolding(s) in Company
1st Apr 20269:00 amRNSIssue of Shares and Total Voting Rights
30th Mar 20262:07 pmRNSDirector/PDMR Shareholding
24th Mar 202610:35 amRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20261:00 pmRNSIssue of Shares and Total Voting Rights
19th Feb 20269:38 amRNSHolding(s) in Company
17th Feb 20263:23 pmRNSDirector/PDMR Shareholding
5th Feb 202611:48 amRNSDirector Declaration
3rd Feb 20269:57 amRNSDirector/PDMR Shareholding
2nd Feb 20269:00 amRNSTotal Voting Rights
29th Jan 202610:18 amRNSHolding(s) in Company
28th Jan 202610:42 amRNSDirector/PDMR Shareholding
12th Jan 20264:38 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSChristmas Trading Results
2nd Jan 20269:00 amRNSTotal Voting Rights
2nd Jan 20269:00 amRNSBlock listing Interim Review
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
11th Dec 202510:00 amRNS2025 PSP Award Targets
10th Dec 202510:39 amRNSDirector/PDMR Shareholding
3rd Dec 20254:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20251:43 pmRNSDirector/PDMR Shareholding
1st Dec 20255:34 pmRNSDirector/PDMR Shareholding
1st Dec 20259:00 amRNSTotal Voting Rights
28th Nov 202512:55 pmRNSDirector/PDMR Shareholding
17th Nov 20259:00 amRNSDirectorate change
12th Nov 20255:11 pmRNSDirector/PDMR Shareholding
12th Nov 20259:00 amRNSDirectorate change
11th Nov 202512:00 pmRNSInvestor Presentation
5th Nov 20257:00 amRNSHalf-year Financial Report
3rd Nov 20259:00 amRNSTotal Voting Rights
30th Oct 202510:00 amRNSDirectorate Change
28th Oct 20254:56 pmRNSDirector/PDMR Shareholding
14th Oct 202510:00 amRNSMarks and Spencer Chairmanship
1st Oct 20259:00 amRNSTotal Voting Rights
30th Sep 202511:36 amRNSDirector/PDMR Shareholding
1st Sep 20259:00 amRNSTotal Voting Rights
28th Aug 20252:23 pmRNSDirector/PDMR Shareholding
20th Aug 20259:30 amRNSDirectorate Change
1st Aug 20259:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.